Skip to main content
. Author manuscript; available in PMC: 2023 May 4.
Published in final edited form as: Int J Cancer. 2022 Nov 5;152(9):2002–2010. doi: 10.1002/ijc.34340

Table 2.

Odds ratios (ORs) and 95% confidence intervals (CIs) for lung cancer in relation to EarlyCDT®-Lung test results in different subgroups

High vs no significant Moderate vs no significant
OR (95% CI) p-value OR (95% CI) p-value

Overall 1.09 (0.48–2.47) 0.84 0.89 (0.34–2.30) 0.81
Cohort
 EPIC 1.67 (0.61–4.59) 0.32 0.83 (0.25–2.73) 0.76
 NSHDS 0.40 (0.08–2.06) 0.27 1.00 (0.20–4.95) 1.00
Sex
 Male 0.75 (0.26–2.16) 0.59 0.71 (0.23–2.25) 0.57
 Female 2.00 (0.50–8.00) 0.33 1.50 (0.25–8.98) 0.66
Smoking status
 Former smokers 1.50 (0.42–5.32) 0.53 2.00 (0.37–10.92) 0.42
 Current smokers 0.83 (0.25–2.73) 0.76 0.57 (0.17–1.95) 0.37
Smoking history
 <20 pack-years 0.40 (0.08–2.06) 0.27 1.00 (0.14–7.10) 1.00
 ≥20 pack-years 2.50 (0.49–12.89) 0.27 0.67 (0.19–2.36) 0.53
Sample collection time before diagnosis
 ≤ 1 year 2.33 (0.60–9.02) 0.22 0.67 (0.11–3.99) 0.66
 > 1 year 0.63 (0.20–1.91) 0.41 1.00 (0.32–3.10) 1.00
Age at sample collection
 ≤ 60 years 0.56 (0.19–1.66) 0.29 1.17 (0.39–3.47) 0.78
 >60 years 6.00 (0.72–49.84) 0.10 0.50 (0.05–5.51) 0.57
Age at diagnosis
 ≤ 60 years 0.67 (0.19–2.36) 0.53 0.80 (0.21–2.98) 0.74
 >60 years 1.60 (0.52–4.89) 0.41 1.00 (0.25–4.00) 1.00
Calendar year of sample collection
 1988–1995 0.83 (0.25–2.73) 0.76 2.50 (0.49–12.89) 0.27
 1996–2016 1.20 (0.37–3.93) 0.76 0.43 (0.11–1.66) 0.22

Abbreviation: EPIC, European Prospective Investigation into Cancer and Nutrition; NSHDS, Northern Sweden Health and Disease Study